1. Biotech Clusters in British Columbia

2. To be the catalyst for a life sciences cluster of genomics-related research institutions and companies working together for the socio-economic benefit of British Columbia and Canada. Our Vision

3. Our History Motivated by the late Dr. Michael Smith, Genome British Columbia was formed in July 2000 by a Board comprised of leaders in BC’s life science research, technology and investment sectors Competition I projects and platforms were announced in April 2001, with an investment in BC of $69M; Competition II projects were announced in April 2002, with a direct investment in BC of $32M and indirect investment in BC of another $13M for a total of $114M The Applied Health Competition was announced in April 2004 with approved projects in BC of $44M

4. Biotechnology in British Columbia – Reference: BC Biotech (2004) BC’s biotechnology industry comprises over 90 private sector firms British Columbia is home to the seventh largest biotech cluster in North America based on the number of biotech companies The majority of biotechnology companies in BC have been spun off from the province’s universities, affiliated teaching hospitals and public sector research institutions

5. Biotechnology in British Columbia – Reference: BC Biotech (2004) BC’s biotechnology industry is dominated by firms in the health care sector (60%), companies developing biopharmaceutical and biomedical applications BC is the fastest growing biotech sector in Canada with a 108% growth rate in the number of core biotech companies from 1997 to 2001

6. Biotechnology in British Columbia – Reference: BC Biotech (2004) Between 1991 and 2001, 60 biotechnology companies were created in Vancouver, making it the third fastest growing in North America, with only San Francisco (71) and Boston (65) having founded more companies in that decade In 2003, British Columbia accounted for 47% of all public and 34% of all private biotech financings in Canada. Total investment in public companies in BC in 2003 was $789,852,500; and total investment in private companies in BC in 2003 was $83,400,000

7. Biotechnology in British Columbia – Reference: BC Biotech (2004) Total venture capital funding for biotech firms in Vancouver from 1998 to 2001 was US$204.1 million compared to the average of US$191.3 million among 52 US centres examined 2002 revenue among BC’s top biotech companies was $165.88 million Total estimated employment by Vancouver biotechnology firms is 2,593. The pharmaceutical industry employs an additional 1,121

8. Reference: White Paper: PwC 2003

15. Cluster Development – Factors CRISIS –eg. Ottawa PAN POLITICAL –eg. Oregon CHAMPIONS –eg. Terry Mathews

16. Cluster Development – Factors ANGELS –eg. Denny Doyle MENTORS AND BOARDS –eg. Haig Farris UNIVERSITIES –eg. UBC Spin-offs

17. Cluster Development – Factors COMPANIES –eg. MPR, QLT 4 th PILLAR ORGANIZATIONS –eg. OCRI; AceTech; Genome BC

18. Cluster Development – Factors NATIONAL –eg. Economical and political sovereignty NAFTA / city states model National model

19. Summary Technology clusters have not reached their potential in BC However, the biotech cluster in BC is well-positioned for growth Reference: The State of Biotechnology in Canada: Current research from the ISRN: May 2004